EGFR and non-small cell lung carcinoma: Given the heterogeneity of tumors, the limitations of biopsies, and the high costs associated with gene testing, there is an urgent need for a more effective, simple, inexpensive, and reproducible method to detect EGFR mutation status in NSCLC.